RxNorm 206275
guaifenesin 180 MG / theophylline 300 MG Oral Capsule [Quibron]
RxNorm Semantic Concepts
RxNorm semantic concepts for the RxCUI 206275 unique identifier include: guaifenesin 180 MG / theophylline 300 MG Oral Capsule [Quibron] (12368363) and guaiFENesin 180 MG / theophylline 300 MG Oral Capsule [Quibron] (12376857).
RxNorm Atom ID: 12368363 - Semantic Branded Drug
guaifenesin 180 MG / theophylline 300 MG Oral Capsule [Quibron]
- RXCUI:
- 206275 - RxNorm Unique Identifier for a concept (Concept ID)
- LAT:
- ENG - Language of the Term
- RXAUI:
- 12368363 - Unique identifier for the atom (RxNorm Atom ID)
- Is Prescribable?
- NO - This drug IS NOT part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.
- Concept Description:
- guaifenesin 180 MG / theophylline 300 MG Oral Capsule [Quibron] - Description of concept identifier
- Term Type (TTY):
- SBD - Term type in source with name and description
- Term Type Name:
- Semantic Branded Drug - Name of term type in source
- Term Type Description:
- Ingredient + Strength + Dose Form + Brand Name - Description of term type in source
- Code:
- 206275 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
- Suppress Flag:
- O
Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility. - CVF:
- - Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
- Source:
- RXNORM - Concept source abbreviation
- Source Name:
- RxNorm Vocabulary - The official name for a source
- Source Version:
- 20AA_240401F - The source version
- Source Date:
- March 04, 2024 - RxNorm data last updated
- Source License Contact:
- RxNorm Customer Service
U.S. National Library of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
(888) FIND-NLM
[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source license contact information - Source Content Contact:
- RxNorm Customer Service
U.S. National Library of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
(888) FIND-NLM
[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source content contact information - Source Short Name:
- RxNorm work done by the National Library of Medicine - The short name of a source as used by the NLM Knowledge Source Server
RxNorm Atom 12368363 Attributes
Property | Value | Explanation |
---|---|---|
RXN AI | {316799} 10438 | RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value |
RXN AM | {316799} 10438 | RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value |
RXN BOSS FROM | {316799} AI | Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value |
RXN OBSOLETED | 04/30/2020 | Date the RxNorm atom became obsolete |
RXTERM FORM | Cap | The RxTerm dose form name for this drug |
RxNorm Atom ID: 12376857 - Tall Man Lettering Synonym
guaiFENesin 180 MG / theophylline 300 MG Oral Capsule [Quibron]
- RXCUI:
- 206275 - RxNorm Unique Identifier for a concept (Concept ID)
- LAT:
- ENG - Language of the Term
- RXAUI:
- 12376857 - Unique identifier for the atom (RxNorm Atom ID)
- Is Prescribable?
- NO - This drug IS NOT part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.
- Concept Description:
- guaiFENesin 180 MG / theophylline 300 MG Oral Capsule [Quibron] - Description of concept identifier
- Term Type (TTY):
- TMSY - Term type in source with name and description
- Term Type Name:
- Tall Man Lettering Synonym - Name of term type in source
- Term Type Description:
- Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. - Description of term type in source
- Code:
- 206275 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
- Suppress Flag:
- O
Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility. - CVF:
- - Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
- Source:
- RXNORM - Concept source abbreviation
- Source Name:
- RxNorm Vocabulary - The official name for a source
- Source Version:
- 20AA_240401F - The source version
- Source Date:
- March 04, 2024 - RxNorm data last updated
- Source License Contact:
- RxNorm Customer Service
U.S. National Library of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
(888) FIND-NLM
[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source license contact information - Source Content Contact:
- RxNorm Customer Service
U.S. National Library of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
(888) FIND-NLM
[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source content contact information - Source Short Name:
- RxNorm work done by the National Library of Medicine - The short name of a source as used by the NLM Knowledge Source Server
* This product uses publicly available data courtesy of the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.